TissueTech has selected the Medidata Rave Clinical Cloud as its end-to-end platform for conducting clinical trials.

The partnership will enable TissueTech to transform in biologics with a focus on regenerative therapies derived from human birth tissue for patients suffering from serious unmet clinical needs.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

TissueTech will use the industry’s end-to-end unified platform which includes Medidata Rave EDC, RTSM, CTMS, eTMF, and eCOA to create a single source of truth from study planning till completion.

The company can optimise operational execution and improve quality, while decreasing the number of e-clinical systems used across study teams.

Medidata’s unified platform, Rave Clinical Cloud, allows TissueTech to focus on intelligent oversight of study, country and site activities.

TissueTech president and CEO Amy Tseng: “The partnership with Medidata further underscores TissueTech’s commitment to evidence-based medicine, scientific integrity and continuous research and innovation.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Medidata’s unified platform provides us with the technology foundation to scale our clinical research, address the complexity of today’s clinical trials, and build and maintain efficiencies as we continue to grow.”

Medidata’s partnership will also enable TissueTech to strengthen its business processes through automatic capture and harmonisation of data from multiple sources to power organised study execution.

The collaboration will also allow TissueTech to provide faster access and real-time visibility into medical images for secure and cost-effective management.

Medidata co-founder and president Glen de Vries: “TissueTech has pioneered the clinical application of human placental tissues, and we’re proud to be part of their journey in developing regenerative therapies for ocular disease, complex wounds, osteoarthritis of the knee, and other patient needs.”